Sunday, June 20, 2021
News

Rutgers reports first instance of COVID-19 triggering recurrent blood clots in arms

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

New Jersey | May 15, 2021 12:44:21 PM IST
A team of researchers at Rutgers Robert Wood Johnson Medical School reported the first instance of COVID-19 triggering a rare recurrence of potentially serious blood clots in people's arms.

The discovery, published in the journal Viruses, improves the understanding of how inflammation caused by COVID-19 can lead to upper extremity blood clots and how best to treat them.

The case study is part of a larger Rutgers study of 1,000 hospitalised patients diagnosed with COVID-19 who were admitted and discharged between March and May 2020.

While there have been reports of lower extremity deep vein thrombosis following COVID-19, this is the first study in which COVID-19 triggered a recurrence in the upper arm of an active 85-year-old man who had a prior diagnosis of upper extremity blood clots.

"The patient presented to his primary care physician with complaints of swelling in his left arm and was sent to the hospital for further management where he was diagnosed with an upper arm blood clot and an asymptomatic COVID-19 infection," said Payal Parikh, an assistant professor of medicine at Rutgers Robert Wood Johnson Medical School, who led the study along with Martin Blaser, director of the Center for Advanced Biotechnology and Medicine and a professor at Rutgers Robert Wood Johnson Medical School.

"While his oxygen levels were not diminished, he was hospitalized for the management of the upper extremity deep vein blood clot. Often, blood clots are preceded by chronic inflammatory conditions exacerbated by immobility, and rarely do they occur in patients who are otherwise healthy and active at baseline," added Parikh.

Most cases of deep vein thrombosis occur in the legs. Only about 10 per cent of blood clots occur in the arms and of those cases only 9 per cent recur.

"This is of concern since, in 30 per cent of these patients, the blood clot can travel to the lung and be possibly fatal," said Parikh. "Other disabling complications include persistent swelling, pain and arm fatigue."

The study suggests that clinicians should consider testing for deep vein thrombosis and COVID-19 in patients who present with complaints of unexplained swelling. People who test positive for COVID-19 should seek medical attention if they have declining oxygen levels, shortness of breath and any unexplained swelling.

"If you have been previously diagnosed with deep vein thrombosis or have a chronic medical illness that predisposes you to blood clots, you have a higher risk for recurrence of a deep vein thrombus in the setting of a COVID-19 infection and thus, should be vigilant," concluded Parikh. (ANI)

 
  LATEST COMMENTS ()
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
 
MORE SCIENCE NEWS
Study discovers compounds that protect l...
Yahoo Mobile announces to shut down afte...
Samsung Galaxy Tab S7 FE perfectly blend...
Sony announces PS5 beta programme ahead ...
Tesla reduces energy capacity of battery...
Facebook rolls out v30 update for Oculus...
More...
 
INDIA WORLD ASIA
Chhattisgarh: Body of woman Naxal, weapo...
India records 58,419 new COVID-19 cases,...
Youth opens fire at lover before shootin...
Students travel 3 kms to access internet...
Father's Day 2021: Tips to pamper your f...
Delhi Police to form district, thana lev...
More...    
 
 Top Stories
AR Rahman collaborates with legenda... 
'No rush' to re-open Australia's bo... 
COVID-19: Gurugram mall, restaurant... 
Kerala Tourism Ministry to launch '... 
Study finds common antibiotic usefu... 
Opposition in Kerala trying to save... 
UP: 3 suffer burn injuries at Bijno... 
Pakistan wanted 'reconciliation' bu...